title: Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.
abstract: Few studies have compared the cobas HPV test to the Aptima HPV assay (AHPV) and the Aptima HPV 16 18/45 genotype assay (AHPV GT) for high-risk human papillomavirus (hrHPV) detection, clinical performance in detecting cervical intraepithelial neoplasia grade 2 (CIN2) or more severe (CIN2+) diagnoses, and risk stratification by partial HPV genotyping. The cobas HPV test is a DNA test that separately and concurrently detects HPV16, HPV18, and a pool of 12 other hrHPV types. AHPV is an RNA test for a pool of 14 hrHPV genotypes, and AHPV GT is an RNA test run on AHPV-positive results to detect HPV16 separately from HPV18 and HPV45, which are detected together. In a population of patients (n=988) referred for colposcopy because of a cervical Pap cytology result of atypical squamous cells of undetermined significance (ASC-US), a cervical scrape specimen was taken, placed into a ThinPrep Pap test vial containing PreservCyt liquid cytology medium, and tested in a blinded fashion with cobas and AHPV and with AHPV GT for AHPV-positive results. The final diagnoses were based on a consensus panel review of the biopsy specimen histology. AHPV and cobas were equally sensitive for CIN2+ diagnoses (89.4% each; P=1.000), and AHPV was more specific than cobas (63.1% versus 59.3%; P≤0.001). The percent total agreement, percent positive agreement, and kappa value were 90.9%, 81.1%, and 0.815, respectively. Risk stratification using partial HPV genotyping was similar for the two assays. AHPV and AHPV GT had similar sensitivity and risk stratification to cobas HPV, but they were more specific than cobas HPV.
authors: Albert Einstein College of Medicine, New York, New York, USA.
authors: Philip E
authors: PE
authors: Castle
authors: Hologic, Inc., San Diego, California, USA.
authors: Barbara
authors: B
authors: Eaton
authors: Hologic, Inc., San Diego, California, USA.
authors: Jennifer
authors: J
authors: Reid
authors: Hologic, Inc., San Diego, California, USA damon.getman@hologic.com.
authors: Damon
authors: D
authors: Getman
authors: Hologic, Inc., San Diego, California, USA.
authors: Janel
authors: J
authors: Dockter
mesh_terms: D000328:Adult; D000368:Aged; D065309:Atypical Squamous Cells of the Cervix / Q000821:virology*; D003127:Colposcopy; D055088:Early Detection of Cancer / Q000379:methods*; D005260:Female; D006801:Humans; D008875:Middle Aged; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D027383:Papillomaviridae / Q000235:genetics / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000821:virology; D011446:Prospective Studies; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D055815:Young Adult
references: Br J Cancer. 2013 Mar 5;108(4):908-13
references: 23370211
references: Lancet Oncol. 2010 Nov;11(11):1048-56
references: 20952254
references: J Clin Microbiol. 2008 Aug;46(8):2595-604
references: 18579716
references: Am J Surg Pathol. 2013 Sep;37(9):1299-310
references: 24076770
references: Gynecol Oncol. 2011 Nov;123(2):278-83
references: 21835440
references: CA Cancer J Clin. 2012 May-Jun;62(3):147-72
references: 22422631
references: Int J Gynecol Pathol. 2013 Jan;32(1):76-115
references: 23202792
references: J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S1-S27
references: 23519301
references: Am J Obstet Gynecol. 2013 Feb;208(2):144.e1-8
references: 23220509
references: Obstet Gynecol. 2008 Apr;111(4):847-56
references: 18378743
references: Biometrics. 2000 Jun;56(2):345-51
references: 10877288
references: J Med Virol. 2004 Sep;74(1):107-16
references: 15258976
references: Obstet Gynecol. 2009 Jan;113(1):18-25
references: 19104355
references: J Clin Microbiol. 2012 Jun;50(6):1867-73
references: 22422852
references: Infect Agent Cancer. 2009 Jun 01;4:8
references: 19486508